We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Targeting vascular endothelial growth factor in advanced carcinoid tumor: a random assignment phase II study of depot octreotide with bevacizumab and pegylated interferon alpha-2b.
- Authors
Yao, James C; Phan, Alexandria; Hoff, Paulo M; Chen, Helen X; Charnsangavej, Chusilp; Yeung, Sai-Ching J; Hess, Kenneth; Ng, Chaan; Abbruzzese, James L; Ajani, Jaffer A
- Abstract
Effective systemic therapy for advanced carcinoid is lacking. The combination of bevacizumab (BEV) and pegylated (PEG) interferon alpha-2b was evaluated among patients with metastatic or unresectable carcinoid tumors.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Vol 26, Issue 8, p1316
- ISSN
1527-7755
- Publication type
Journal Article
- DOI
10.1200/JCO.2007.13.6374